Johnson Johnson Aktie
Es gab keine Analysen zu dieser Aktie in den letzten sechs Monaten.
Kursziele der Johnson Johnson-Aktie in
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Alexion Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| Allergan Inc. | 0 | 0 | 0 | - | - |
| APONTIS PHARMA | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 8 | 0 | 1 | 164,21 GBP | - |
| Bayer | 7 | 2 | 0 | 55,31 EUR | +12,60% |
| Beiersdorf AG | 1 | 7 | 2 | 78,44 EUR | -1,75% |
| BioNTech (ADRs) | 5 | 1 | 0 | 128,83 USD | +38,83% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| Celgene Corp. | 0 | 0 | 0 | - | - |
| CureVac | 0 | 0 | 0 | - | - |
| Douglas AG | 2 | 3 | 0 | 10,40 EUR | +27,14% |
| Fresenius Medical Care (FMC) St. | 2 | 4 | 3 | 40,81 EUR | -3,61% |
| Fresenius SE & Co. KGaA (St.) | 6 | 1 | 0 | 54,28 EUR | +14,64% |
| GSK PLC Registered Shs | 2 | 5 | 2 | 21,17 GBP | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 4 | 4 | 0 | 141,00 EUR | 0,00% |
| Moderna Inc | 0 | 1 | 0 | 45,00 USD | -25,71% |
| MorphoSys | 0 | 0 | 0 | - | - |
| Nestlé SA (Nestle) | 4 | 6 | 0 | 87,89 CHF | +9,63% |
| Novartis AG | 2 | 6 | 1 | 123,10 CHF | -2,19% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 2 | 5 | 1 | 27,14 USD | +1,95% |
| Procter & Gamble Co. | 0 | 0 | 0 | - | - |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 5 | 4 | 0 | 93,53 EUR | +23,73% |
| Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
| STADA | 0 | 0 | 0 | - | - |
| Unilever PLC | 4 | 4 | 2 | 50,42 GBP | - |
| Valneva | 0 | 0 | 0 | - | - |




